Ethical considerations attend decisions about disclosing a likely dementia diagnosis. They begin with patient autonomy – a core value of medicine.Read More
From increased risks to effective screening approaches, special pediatric considerations and the role of medications, our expert shares insights on the intersection of seizures and suicidality.
Child and adolescent psychiatrists are increasingly asked to work with transgender youth, but many have no training with this patient population. An expert shares his approach.
This novel infusion therapy could be a breakthrough for postpartum depression, but its administration is complex and highly regulated. Three psychiatrists outline how we’ll introduce it in our health system.
The newly approved intranasal ketamine derivative helps fill clear gaps in short-term therapy, says one expert, but questions remain around its long-term effects and affordability.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Making clear that your practice is a safe space for LGBTQ youth is a huge first step toward easing the anxieties of teens needing care as they struggle with sexual identity issues.
Cleveland Clinic is co-directing a newly launched NIH clinical trial that aims to better understand — and potentially target — the mind and body factors behind suboptimal bariatric surgery outcomes.
Ketamine has emerged as an alternative to electroconvulsive therapy for treatment-resistant depression, but no study has compared the two. A major research project led by Cleveland Clinic is changing that.
An expert panel at Cleveland Clinic’s Medical Innovation Summit explores lessons from the failed controlled trials of DBS for depression — and the striking reasons for continued interest in this approach.